These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22185227)

  • 1. Detection of low prevalence somatic mutations in solid tumors with ultra-deep targeted sequencing.
    Harismendy O; Schwab RB; Bao L; Olson J; Rozenzhak S; Kotsopoulos SK; Pond S; Crain B; Chee MS; Messer K; Link DR; Frazer KA
    Genome Biol; 2011 Dec; 12(12):R124. PubMed ID: 22185227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of ultra-deep targeted sequencing for personalized breast cancer care.
    Harismendy O; Schwab RB; Alakus H; Yost SE; Matsui H; Hasteh F; Wallace AM; Park HL; Madlensky L; Parker B; Carpenter PM; Jepsen K; Anton-Culver H; Frazer KA
    Breast Cancer Res; 2013 Dec; 15(6):R115. PubMed ID: 24326041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiregion ultra-deep sequencing reveals early intermixing and variable levels of intratumoral heterogeneity in colorectal cancer.
    Suzuki Y; Ng SB; Chua C; Leow WQ; Chng J; Liu SY; Ramnarayanan K; Gan A; Ho DL; Ten R; Su Y; Lezhava A; Lai JH; Koh D; Lim KH; Tan P; Rozen SG; Tan IB
    Mol Oncol; 2017 Feb; 11(2):124-139. PubMed ID: 28145097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic copy number alterations detected by ultra-deep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma.
    Peng CH; Liao CT; Ng KP; Tai AS; Peng SC; Yeh JP; Chen SJ; Tsao KC; Yen TC; Hsieh WP
    Oncotarget; 2015 Aug; 6(23):19891-906. PubMed ID: 26087196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Ultra-Deep Targeted Sequencing Gene Panel Improves the Prognostic Stratification of Patients With Advanced Oral Cavity Squamous Cell Carcinoma.
    Liao CT; Chen SJ; Lee LY; Hsueh C; Yang LY; Lin CY; Fan KH; Wang HM; Ng SH; Lin CH; Tsao CK; Chen IH; Chang KP; Huang SF; Kang CJ; Chen HC; Yen TC
    Medicine (Baltimore); 2016 Feb; 95(8):e2751. PubMed ID: 26937903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing.
    Andersson C; Fagman H; Hansson M; Enlund F
    Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Capture and Amplicon-Based Approaches for the Development of a Targeted Next-Generation Sequencing Pipeline to Personalize Lymphoma Management.
    Hung SS; Meissner B; Chavez EA; Ben-Neriah S; Ennishi D; Jones MR; Shulha HP; Chan FC; Boyle M; Kridel R; Gascoyne RD; Mungall AJ; Marra MA; Scott DW; Connors JM; Steidl C
    J Mol Diagn; 2018 Mar; 20(2):203-214. PubMed ID: 29429887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clonal relationships between pre-cancer and cancer revealed by ultra-deep sequencing.
    Wood HM; Conway C; Daly C; Chalkley R; Berri S; Senguven B; Stead L; Ross L; Egan P; Chengot P; Graham J; Sethi N; Ong TK; High A; MacLennan K; Rabbitts P
    J Pathol; 2015 Nov; 237(3):296-306. PubMed ID: 26096211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of KRAS, NRAS and BRAF hotspot mutations detection for patients with metastatic colorectal cancer using direct DNA pipetting in a fully-automated platform and Next-Generation Sequencing for laboratory workflow optimisation.
    Gilson P; Franczak C; Dubouis L; Husson M; Rouyer M; Demange J; Perceau M; Leroux A; Merlin JL; Harlé A
    PLoS One; 2019; 14(7):e0219204. PubMed ID: 31265477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards a Next-Generation Sequencing Diagnostic Service for Tumour Genotyping: A Comparison of Panels and Platforms.
    Burghel GJ; Hurst CD; Watson CM; Chambers PA; Dickinson H; Roberts P; Knowles MA
    Biomed Res Int; 2015; 2015():478017. PubMed ID: 26351634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
    Pécuchet N; Legras A; Laurent-Puig P; Blons H
    Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Nine Somatic Variant Callers for Detection of Somatic Mutations in Exome and Targeted Deep Sequencing Data.
    Krøigård AB; Thomassen M; Lænkholm AV; Kruse TA; Larsen MJ
    PLoS One; 2016; 11(3):e0151664. PubMed ID: 27002637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.
    Cheng DT; Mitchell TN; Zehir A; Shah RH; Benayed R; Syed A; Chandramohan R; Liu ZY; Won HH; Scott SN; Brannon AR; O'Reilly C; Sadowska J; Casanova J; Yannes A; Hechtman JF; Yao J; Song W; Ross DS; Oultache A; Dogan S; Borsu L; Hameed M; Nafa K; Arcila ME; Ladanyi M; Berger MF
    J Mol Diagn; 2015 May; 17(3):251-64. PubMed ID: 25801821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study.
    Beltrame L; Di Marino M; Fruscio R; Calura E; Chapman B; Clivio L; Sina F; Mele C; Iatropoulos P; Grassi T; Fotia V; Romualdi C; Martini P; Noris M; Paracchini L; Craparotta I; Petrillo M; Milani R; Perego P; Ravaggi A; Zambelli A; Ronchetti E; D'Incalci M; Marchini S
    Ann Oncol; 2015 Jul; 26(7):1363-71. PubMed ID: 25846551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultra-Sensitive TP53 Sequencing for Cancer Detection Reveals Progressive Clonal Selection in Normal Tissue over a Century of Human Lifespan.
    Salk JJ; Loubet-Senear K; Maritschnegg E; Valentine CC; Williams LN; Higgins JE; Horvat R; Vanderstichele A; Nachmanson D; Baker KT; Emond MJ; Loter E; Tretiakova M; Soussi T; Loeb LA; Zeillinger R; Speiser P; Risques RA
    Cell Rep; 2019 Jul; 28(1):132-144.e3. PubMed ID: 31269435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of an integrated clinical workflow for targeted next-generation sequencing of low-quality tumor DNA using a 51-gene enrichment panel.
    Choudhary A; Mambo E; Sanford T; Boedigheimer M; Twomey B; Califano J; Hadd A; Oliner KS; Beaudenon S; Latham GJ; Adai AT
    BMC Med Genomics; 2014 Nov; 7():62. PubMed ID: 25395014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of Next-Generation Sequencing of Entire Mitochondrial Genomes and the Diversity of Mitochondrial DNA Mutations in Oral Squamous Cell Carcinoma.
    Kloss-Brandstätter A; Weissensteiner H; Erhart G; Schäfer G; Forer L; Schönherr S; Pacher D; Seifarth C; Stöckl A; Fendt L; Sottsas I; Klocker H; Huck CW; Rasse M; Kronenberg F; Kloss FR
    PLoS One; 2015; 10(8):e0135643. PubMed ID: 26262956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
    Au CH; Wa A; Ho DN; Chan TL; Ma ES
    Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-specificity detection of rare alleles with Paired-End Low Error Sequencing (PELE-Seq).
    Preston JL; Royall AE; Randel MA; Sikkink KL; Phillips PC; Johnson EA
    BMC Genomics; 2016 Jun; 17():464. PubMed ID: 27301885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel framework for analyzing somatic copy number aberrations and tumor subclones for paired heterogeneous tumor samples.
    Xia H; Li A; Yu Z; Liu X; Feng H
    Biomed Mater Eng; 2015; 26 Suppl 1():S1845-53. PubMed ID: 26405956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.